Identification of Immune-Related lncRNA Signature to Predict Prognosis and Immunotherapeutic Efficiency in Bladder Cancer

Identification of Immune-Related lncRNA Signature to Predict Prognosis and Immunotherapeutic Efficiency in Bladder Cancer

PurposeIdentify immune-related lncRNA (IRL) signature related to the prognosis and immunotherapeutic efficiency for bladder cancer (BLCA) patients.MethodsA total of 397 samples, which contained RNA-seq and clinical information from The Cancer Genome Atlas (TCGA) database, were used for the following...

Full description

Bibliographic Details
Main Authors:	Lianghao Zhang, Longqing Li, Yonghao Zhan, Jiange Wang, Zhaowei Zhu, Xuepei Zhang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-01-01
Series:	Frontiers in Oncology
Subjects:	bladder cancer The Cancer Genome Atlas immune-related long noncoding RNA prognosis tumor immune microenvironment
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2020.542140/full

Similar Items

Identification of a tumor microenvironment-related seven-gene signature for predicting prognosis in bladder cancer
by: Zhi Wang, et al.
Published: (2021-06-01)

A 7-lncRNA signature associated with the prognosis of colon adenocarcinoma
by: Xiaorui Fu, et al.
Published: (2020-04-01)

Identification of an IRGP Signature to Predict Prognosis and Immunotherapeutic Efficiency in Bladder Cancer
by: Liang-Hao Zhang, et al.
Published: (2021-04-01)

Identification and validation of a hypoxia-related prognostic and immune microenvironment signature in bladder cancer
by: Xianchao Sun, et al.
Published: (2021-05-01)

Immune-related long non-coding RNA signature identified prognosis and immunotherapeutic efficiency in bladder cancer (BLCA)
by: Rui Cao, et al.
Published: (2020-06-01)

Classification of Muscle-Invasive Bladder Cancer Based on Immunogenomic Profiling
by: Xianghong Zhou, et al.
Published: (2020-08-01)

Identification and Validation of a Novel Immune-Related lncRNA Signature for Bladder Cancer
by: Shan Hua, et al.
Published: (2021-07-01)

Identification of a Genome Instability-Associated LncRNA Signature for Prognosis Prediction in Colon Cancer
by: Tengfei Yin, et al.
Published: (2021-06-01)

Identification of a Hypoxia-Related Signature for Predicting Prognosis and the Immune Microenvironment in Bladder Cancer
by: Minxiao Jiang, et al.
Published: (2021-05-01)

Bioinformatics Analysis Finds Immune Gene Markers Related to the Prognosis of Bladder Cancer
by: Xingyu Chen, et al.
Published: (2020-06-01)

Systematic analyses of a novel lncRNA‐associated signature as the prognostic biomarker for Hepatocellular Carcinoma
by: Jing Sui, et al.
Published: (2018-07-01)

N6-Methylandenosine-Related lncRNAs Predict Prognosis and Immunotherapy Response in Bladder Cancer
by: Yuying Zhang, et al.
Published: (2021-08-01)

In silico analysis of the immune microenvironment in bladder cancer
by: Ye Zhang, et al.
Published: (2020-03-01)

Down-regulation LncRNA-SNHG15 contributes to proliferation and invasion of bladder cancer cells
by: Aldhabi Mokhtar, et al.
Published: (2021-05-01)

Modifying the Non-muscle Invasive Bladder Cancer Immune Microenvironment for Optimal Therapeutic Response
by: Nicola E. Annels, et al.
Published: (2020-02-01)

An Immune Gene-Related Five-lncRNA Signature for to Predict Glioma Prognosis
by: Xinzhuang Wang, et al.
Published: (2020-12-01)

A novel immune-related gene pair prognostic signature for predicting overall survival in bladder cancer
by: Yang Fu, et al.
Published: (2021-07-01)

Characterization of hypoxia response patterns identified prognosis and immunotherapy response in bladder cancer
by: Rui Cao, et al.
Published: (2021-09-01)

Extracellular Matrix–Related Six-lncRNA Signature as a Novel Prognostic Biomarker for Bladder Cancer
by: Qing L, et al.
Published: (2020-12-01)

Identification of Immune-Related Subtypes and Characterization of Tumor Microenvironment Infiltration in Bladder Cancer
by: Mengjia Huang, et al.
Published: (2021-08-01)

RNA-Sequencing Data Reveal a Prognostic Four-lncRNA-Based Risk Score for Bladder Urothelial Carcinoma: An in Silico Update
by: Rong-Quan He, et al.
Published: (2018-10-01)

An immune relevant signature for predicting prognoses and immunotherapeutic responses in patients with muscle‐invasive bladder cancer (MIBC)
by: Wen Jiang, et al.
Published: (2020-04-01)

An Exploration of the Tumor Microenvironment Identified a Novel Five-Gene Model for Predicting Outcomes in Bladder Cancer
by: Xinjie Li, et al.
Published: (2021-05-01)

Analysis of Tumor Microenvironment Characteristics in Bladder Cancer: Implications for Immune Checkpoint Inhibitor Therapy
by: Xingyu Chen, et al.
Published: (2021-04-01)

Identification and Validation of a Stromal EMT Related LncRNA Signature as a Potential Marker to Predict Bladder Cancer Outcome
by: YiHeng Du, et al.
Published: (2021-03-01)

Identification and Validation of Immune-Related lncRNA Signature as a Prognostic Model for Skin Cutaneous Melanoma
by: Ping S, et al.
Published: (2021-06-01)

ATM Mutations Benefit Bladder Cancer Patients Treated With Immune Checkpoint Inhibitors by Acting on the Tumor Immune Microenvironment
by: Ruibin Yi, et al.
Published: (2020-08-01)

Expression of RCAS1 Correlates with Urothelial Bladder Cancer Malignancy
by: Wojciech Jóźwicki, et al.
Published: (2015-02-01)

Prognostic Implications of Pan-Cancer CMTM6 Expression and Its Relationship with the Immune Microenvironment
by: Yanbin Zhao, et al.
Published: (2021-01-01)

Tumor Expression Profile Analysis Developed and Validated a Prognostic Model Based on Immune-Related Genes in Bladder Cancer
by: Bingqi Dong, et al.
Published: (2021-08-01)

Comprehensive Analysis of Correlations in the Expression of miRNA Genes and Immune Checkpoint Genes in Bladder Cancer Cells
by: Przemysław A. Stempor, et al.
Published: (2021-03-01)

A Ferroptosis-Related lncRNAs Signature Predicts Prognosis and Immune Microenvironment for Breast Cancer
by: Kaiming Zhang, et al.
Published: (2021-06-01)

lncRNA SLCO4A1-AS1 promotes growth and invasion of bladder cancer through sponging miR-335-5p to upregulate OCT4
by: Yang Y, et al.
Published: (2019-02-01)

LncRNAs specifically overexpressed in endocervical adenocarcinoma are associated with an unfavorable recurrence prognosis and the immune response
by: Yong Song, et al.
Published: (2021-09-01)

A hypoxia related long non-coding RNA signature could accurately predict survival outcomes in patients with bladder cancer
by: Facai Zhang, et al.
Published: (2021-01-01)

Identification of Signature Genes Associated With Invasiveness and the Construction of a Prognostic Model That Predicts the Overall Survival of Bladder Cancer
by: Yang He, et al.
Published: (2021-09-01)

Identification of the 3-lncRNA Signature as a Prognostic Biomarker for Colorectal Cancer
by: Shuzhen Liu, et al.
Published: (2020-12-01)

Identification and potential mechanisms of a 4-lncRNA signature that predicts prognosis in patients with laryngeal cancer
by: Guihai Zhang, et al.
Published: (2019-08-01)

A novel signature constructed by ferroptosis-associated genes (FAGs) for the prediction of prognosis in bladder urothelial carcinoma (BLCA) and associated with immune infiltration
by: Jiao-chen Luan, et al.
Published: (2021-08-01)

Integrative analysis of the lncRNA-associated ceRNA network reveals lncRNAs as potential prognostic biomarkers in human muscle-invasive bladder cancer
by: Lyu L, et al.
Published: (2019-07-01)